Molecular Partners Stock Forecast - Risk Adjusted Performance
| MOLN Stock | USD 4.28 0.10 2.39% |
Molecular Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Molecular Partners stock prices and determine the direction of Molecular Partners AG's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Molecular Partners' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Molecular Partners' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Molecular Partners' systematic risk associated with finding meaningful patterns of Molecular Partners fundamentals over time.
Check out Historical Fundamental Analysis of Molecular Partners to cross-verify your projections. Molecular |
Most investors in Molecular Partners cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Molecular Partners' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Molecular Partners' price structures and extracts relationships that further increase the generated results' accuracy.
| Check Molecular Partners Volatility | Backtest Molecular Partners | Information Ratio |
Molecular Partners Trading Date Momentum
| On June 07 2024 Molecular Partners AG was traded for 4.28 at the closing time. The top price for the day was 4.28 and the lowest listed price was 4.28 . There was no trading activity during the period 0.0. Lack of trading volume on June 7, 2024 did not cause price change. The trading delta at closing time against the current closing price is 2.34% . |
| Compare Molecular Partners to competition |
Other Forecasting Options for Molecular Partners
For every potential investor in Molecular, whether a beginner or expert, Molecular Partners' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Molecular Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Molecular. Basic forecasting techniques help filter out the noise by identifying Molecular Partners' price trends.Molecular Partners Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Molecular Partners stock to make a market-neutral strategy. Peer analysis of Molecular Partners could also be used in its relative valuation, which is a method of valuing Molecular Partners by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Molecular Partners Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Molecular Partners' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Molecular Partners' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Molecular Partners Market Strength Events
Market strength indicators help investors to evaluate how Molecular Partners stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Molecular Partners shares will generate the highest return on investment. By undertsting and applying Molecular Partners stock market strength indicators, traders can identify Molecular Partners AG entry and exit signals to maximize returns.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.02 | |||
| Day Median Price | 4.28 | |||
| Day Typical Price | 4.28 | |||
| Price Action Indicator | 0.05 | |||
| Period Momentum Indicator | 0.1 |
Molecular Partners Risk Indicators
The analysis of Molecular Partners' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Molecular Partners' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting molecular stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.27 | |||
| Semi Deviation | 4.39 | |||
| Standard Deviation | 4.75 | |||
| Variance | 22.58 | |||
| Downside Variance | 30.94 | |||
| Semi Variance | 19.26 | |||
| Expected Short fall | (3.78) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Information and Resources on Investing in Molecular Stock
When determining whether Molecular Partners offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Molecular Partners' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Molecular Partners Ag Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Molecular Partners Ag Stock:Check out Historical Fundamental Analysis of Molecular Partners to cross-verify your projections. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Molecular Partners. If investors know Molecular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Molecular Partners listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.99) | Revenue Per Share 0.205 | Quarterly Revenue Growth (0.10) | Return On Assets (0.18) | Return On Equity (0.30) |
The market value of Molecular Partners is measured differently than its book value, which is the value of Molecular that is recorded on the company's balance sheet. Investors also form their own opinion of Molecular Partners' value that differs from its market value or its book value, called intrinsic value, which is Molecular Partners' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Molecular Partners' market value can be influenced by many factors that don't directly affect Molecular Partners' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Molecular Partners' value and its price as these two are different measures arrived at by different means. Investors typically determine if Molecular Partners is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Molecular Partners' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.